Public Comments to Agencies
Coalition Comments to FDA on the Development of the Biosimilars Market
September 21, 2018 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane Room 1061, HFA-305 Rockville, MD 20852
Comments to FCC on the T-Mobile and Sprint Merger
September 17, 2018 Chairman Ajit Pai Federal Communications Commission 445 12th Street, SW Washington, D.C. 20554
Comments to CMS on Proposed Rule for Changes to Hospital Outpatient Prospective Payment System for Off-Campus Sites
August 23, 2018 Centers for Medicare and Medicaid Services Department of Health and Human Services P.O. Box 8013 Baltimore, MD 21244-1850
Comment on FDA's Proposed Rule Regarding Nicotine Levels
July 11, 2018 Food and Drug Administration (FDA) 5630 Fishers Lane Room 1061 Rockville, MD 20852 Comment on FDA’s Advanced Notice of Proposed Rule Making regarding Tobacco Product Standard for Nicotine Level of Combusted Cigarettes
Comment on FDA's Proposed Rule Regarding Tobacco Product Flavors
July 11, 2018 Food and Drug Administration (FDA) 5630 Fishers Lane Room 1061 Rockville, MD 20852 Comment on FDA’s Advanced Notice of Proposed Rule Making regarding Regulations of Flavors in Tobacco Products Docket ID No – FDA-2017-N-6565
Comment on EPA's Proposed Rule to Strengthen Transparency in Regulatory Science
May 25, 2018 Environmental Protection Agency (EPA) EPA Docket Center (EPA/DC) 1200 Pennsylvania Avenue, NW Washington, DC 20460 Comment on EPA’s Proposed Rule to Strengthen Transparency in Regulatory Science Docket ID No. EPA-HQ-OA-2018-0259
Comments to WHO on Tobacco Harm-Reduction Products
May 16, 2018 World Health Organization Independent High-Level Commission On Non-Communicable Diseases Re: Comments on May 1, 2018, First Draft Report
Comments to FDA on Modified Risk Tobacco Product Applications
March 21, 2018 Commissioner Scott Gottlieb, M.D. Food and Drug Administration Dockets Management Staff HFA-305 5630 Fishers Lane Room 1061 Rockville, Maryland 20852 Attention
Comments on FCC 2018 Lifeline Reform Proposal
[PDF DOWNLOAD] BEFORE THE FEDERAL COMMUNICATIONS COMMISSION
Comments to FDA Tobacco Products Scientific Advisory Committee
December 11, 2017 Caryn Cohen, M.S. Office of Science Center for Tobacco Products Food and Drug Administration Document Control Center Building 71, Room G335 10903 New Hampshire Avenue Silver Spring, MD 20993-0002
CAGW Comments on Federal Motor Vehicle Safety Standards: V2V Communications
September 7, 2017 The Honorable Elaine Chao Secretary U.S. Department of Transportation 1200 New Jersey Avenue, S.E. Washington, D.C. 20590 Ref: Federal Motor Vehicle Safety Standards: V2V Communications Docket No. NHTSA-2016-0126
Centers for Medicare and Medicaid Comments on Biosimilars
August 28, 2017 Centers for Medicare and Medicaid Department of Health and Human Services P.O. Box 8016 Baltimore, Maryland 21244-8013
